UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Nature medicine, 2022-04, Vol.28 (4), p.724-734

2022

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer

Analytical chemistry (Washington), 2020-03, Vol.92 (5), p.3867-3873

2020

Link zum Volltext

Verfügbarkeit prüfen

Alkaline Phosphatase-Triggered in Situ Formation of Silicon-Containing Nanoparticles for a Fluorometric and Colorimetric Dual-Channel Immunoassay

Analytical chemistry (Washington), 2020-03, Vol.92 (6), p.4639-4646

2020

Link zum Volltext

Verfügbarkeit prüfen

Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity

Clinical cancer research, 2020-06, Vol.26 (12), p.2946-2955

2020

Link zum Volltext

Verfügbarkeit prüfen

Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis

Scientific reports, 2019-09, Vol.9 (1), p.13772-16, Article 13772

2019

Link zum Volltext

Verfügbarkeit prüfen

Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

European urology, 2016-03, Vol.69 (3), p.393-396

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients

The Prostate, 2019-11, Vol.79 (15), p.1767-1776

2019

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer

ACS nano, 2017-05, Vol.11 (5), p.4926-4933

2017

Link zum Volltext

Verfügbarkeit prüfen

Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors

Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1761-1775

2016

Link zum Volltext

Verfügbarkeit prüfen

Correlation between PSA kinetics and PSMA‐PET in prostate cancer restaging: A meta‐analysis

European journal of clinical investigation, 2019-03, Vol.49 (3), p.e13063-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression

Endocrine-related cancer, 2019-02, Vol.26 (2), p.131-146

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer Biomarker Detection in Serum Samples Using Surface Plasmon Resonance and Quartz Crystal Microbalance Sensors with Nanoparticle Signal Amplification

Analytical chemistry (Washington), 2012-07, Vol.84 (14), p.5898-5904

2012

Link zum Volltext

Verfügbarkeit prüfen

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

Annals of oncology, 2017-05, Vol.28 (5), p.1090-1097

2017

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

Proceedings of the National Academy of Sciences - PNAS, 2020-06, Vol.117 (22), p.12315-12323

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

European journal of nuclear medicine and molecular imaging, 2018-05, Vol.45 (5), p.860-877

2018

Link zum Volltext

Verfügbarkeit prüfen

The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease

British journal of pharmacology, 2016-11, Vol.173 (21), p.3041-3079

2016

Link zum Volltext

Verfügbarkeit prüfen

Highly Sensitive Biosensing Using Arrays of Plasmonic Au Nanodisks Realized by Nanoimprint Lithography

ACS nano, 2011-02, Vol.5 (2), p.897-904

2011

Link zum Volltext

Verfügbarkeit prüfen

Glycans as Biomarkers in Prostate Cancer

International journal of molecular sciences, 2019-03, Vol.20 (6), p.1389

2019

Link zum Volltext

Verfügbarkeit prüfen

Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

PloS one, 2015-11, Vol.10 (11), p.e0143283-e0143283

2015

Link zum Volltext

Verfügbarkeit prüfen

Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer

ACS nano, 2018-04, Vol.12 (4), p.3714-3725

2018

Link zum Volltext

Verfügbarkeit prüfen

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Oncotarget, 2016-08, Vol.7 (33), p.52810-52817

2016

Link zum Volltext

Verfügbarkeit prüfen

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

Science translational medicine, 2010-03, Vol.2 (25), p.25ra23

2010

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort

BJU international, 2016-03, Vol.117 (3), p.401-408

2016

Link zum Volltext

Verfügbarkeit prüfen

Personalized strategies in population screening for prostate cancer

International journal of cancer, 2020-12, Vol.147 (11), p.2977-2987

2020

Link zum Volltext

Verfügbarkeit prüfen

Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy

The Prostate, 2007-09, Vol.67 (12), p.1277-1284

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 6.188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.883)
Mit Volltextzugriff
(5.432)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(5.925)
Male
(5.658)
Science & Technology
(5.515)
Life Sciences & Biomedicine
(5.235)
Prostate Cancer
(2.846)
Aged
(2.542)
Middle Aged
(2.524)
Prostate-Specific Antigen - Metabolism
(2.374)
Prostatic Neoplasms - Pathology
(2.357)
Prostatic Neoplasms - Metabolism
(2.047)
Biological And Medical Sciences
(2.010)
Urology & Nephrology
(1.961)
Prostate-Specific Antigen - Blood
(1.927)
Medical Sciences
(1.856)
Oncology
(1.785)
Prostate-Specific Antigen
(1.471)
Endocrinology & Metabolism
(1.396)
Nephrology. Urinary Tract Diseases
(1.274)
Tumors
(1.240)
Urinary Tract. Prostate Gland
(1.209)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer

Alkaline Phosphatase-Triggered in Situ Formation of Silicon-Containing Nanoparticles for a Fluorometric and Colorimetric Dual-Channel Immunoassay

Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity

Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis

Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy

Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients

Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer

Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors

Correlation between PSA kinetics and PSMA‐PET in prostate cancer restaging: A meta‐analysis

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression

Cancer Biomarker Detection in Serum Samples Using Surface Plasmon Resonance and Quartz Crystal Microbalance Sensors with Nanoparticle Signal Amplification

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease

Highly Sensitive Biosensing Using Arrays of Plasmonic Au Nanodisks Realized by Nanoimprint Lithography

Glycans as Biomarkers in Prostate Cancer

Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort

Personalized strategies in population screening for prostate cancer

Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy

Suchergebnisse filtern